- Home
- SKK vs ZBIO Comparison
SKK vs ZBIO Comparison
Compare SKK & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKK
- ZBIO
- Stock Information
- Founded
- SKK 2013
- ZBIO 2019
- Country
- SKK Singapore
- ZBIO United States
- Employees
- SKK N/A
- ZBIO N/A
- Industry
- SKK
- ZBIO
- Sector
- SKK
- ZBIO
- Exchange
- SKK NYSE
- ZBIO NYSE
- Market Cap
- SKK N/A
- ZBIO 339.3M
- IPO Year
- SKK 2024
- ZBIO 2024
- Fundamental
- Price
- SKK $0.95
- ZBIO $8.12
- Analyst Decision
- SKK
- ZBIO Strong Buy
- Analyst Count
- SKK 0
- ZBIO 5
- Target Price
- SKK N/A
- ZBIO $31.75
- AVG Volume (30 Days)
- SKK 3.4M
- ZBIO 458.9K
- Earning Date
- SKK 02-14-2025
- ZBIO 02-16-2025
- Dividend Yield
- SKK N/A
- ZBIO N/A
- EPS Growth
- SKK N/A
- ZBIO N/A
- EPS
- SKK N/A
- ZBIO N/A
- Revenue
- SKK $8,631,000.00
- ZBIO N/A
- Revenue This Year
- SKK N/A
- ZBIO N/A
- Revenue Next Year
- SKK N/A
- ZBIO N/A
- P/E Ratio
- SKK N/A
- ZBIO N/A
- Revenue Growth
- SKK N/A
- ZBIO N/A
- 52 Week Low
- SKK $0.61
- ZBIO $7.50
- 52 Week High
- SKK $11.45
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- SKK N/A
- ZBIO N/A
- Support Level
- SKK N/A
- ZBIO N/A
- Resistance Level
- SKK N/A
- ZBIO N/A
- Average True Range (ATR)
- SKK 0.00
- ZBIO 0.00
- MACD
- SKK 0.00
- ZBIO 0.00
- Stochastic Oscillator
- SKK 0.00
- ZBIO 0.00
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.